Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration...
The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.
New research backed up previous findings, showing a substantially higher risk for severe hypocalcemia in older patients on kidney dialysis than in those treated with oral bisphosphonates.